HomeALT • NASDAQ
add
Altimmune Inc
Previous close
$8.87
Day range
$8.58 - $9.50
Year range
$2.09 - $14.84
Market cap
630.97M USD
Avg Volume
3.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 5.00K | -76.19% |
Operating expense | 5.31M | 17.24% |
Net income | -24.39M | -21.52% |
Net profit margin | -487.88K | -410.39% |
Earnings per share | -0.34 | 15.00% |
EBITDA | -26.69M | -23.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 182.02M | 9.83% |
Total assets | 188.36M | 0.68% |
Total liabilities | 15.42M | -20.31% |
Total equity | 172.94M | — |
Shares outstanding | 70.90M | — |
Price to book | 3.64 | — |
Return on assets | -33.58% | — |
Return on capital | -36.38% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -24.39M | -21.52% |
Cash from operations | -16.36M | 15.72% |
Cash from investing | -39.52M | -397.11% |
Cash from financing | -261.00K | 13.58% |
Net change in cash | -56.14M | -776.21% |
Free cash flow | -7.49M | 39.65% |
About
Founded
1997
Headquarters
Website
Employees
59